Basic Study
Copyright ©The Author(s) 2020.
World J Gastroenterol. Jan 14, 2020; 26(2): 134-153
Published online Jan 14, 2020. doi: 10.3748/wjg.v26.i2.134
Figure 8
Figure 8 Schematic diagram of the main altered pathway in the high- and low-risk patients. TME: tumor microenvironment; DAB2: Disabled homolog 2; MSC: Musculin; CXCL8: C-X-C Motif chemokine ligand 8; LGALS3: Galectin 3; BATF: B-Cell-activating transcription factor; KLRB1: Killer cell lectin like receptor B1; ENG: Endoglin; APCS: Adenomatosis polyposis coli tumor suppressor.